Expand LEXX Menu
LEXX MENU

LEXX Latest Press Releases

-- July 6, 2026 --

Lexaria Updates Business Development ACCESS Newswire 9:10 AM

-- June 25, 2026 --

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule ACCESS Newswire 9:10 AM

-- June 23, 2026 --

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule ACCESS Newswire 9:25 AM

-- June 17, 2026 --

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand ACCESS Newswire 9:25 AM

-- June 9, 2026 --

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway ACCESS Newswire 9:25 AM

-- June 3, 2026 --

Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program ACCESS Newswire 9:25 AM

-- May 19, 2026 --

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 ACCESS Newswire 9:15 AM

-- May 7, 2026 --

Lexaria Bioscience Releases Second Episode of Investor Video Series ACCESS Newswire 9:25 AM

-- May 5, 2026 --

Lexaria Updates Progress on Human Study #7 ACCESS Newswire 9:10 AM

-- May 1, 2026 --

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications ACCESS Newswire 9:25 AM

-- April 29, 2026 --

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended ACCESS Newswire 9:10 AM

-- April 23, 2026 --

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs ACCESS Newswire 9:05 AM

-- April 21, 2026 --

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales ACCESS Newswire 9:10 AM

-- April 15, 2026 --

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property ACCESS Newswire 9:10 AM

-- April 7, 2026 --

Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval ACCESS Newswire 9:10 AM

-- April 1, 2026 --

Lexaria to Begin New Human Clinical Study in GLP-1 ACCESS Newswire 9:20 AM

-- March 26, 2026 --

Lexaria's Robust Patent Portfolio Continues to Grow ACCESS Newswire 9:20 AM

-- March 24, 2026 --

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry ACCESS Newswire 9:15 AM

-- March 4, 2026 --

Lexaria Announces New R&D Plans for 2026 ACCESS Newswire 9:25 AM
Market Data Delayed 15 Minutes